Wakaaladda Daawooyinka Yurub (EMA) ayaa hadda ogolaatay maamulka 12-17 sano jir ee tallaalka ka dhanka ah Covid-19, Moderna. Ilaa hadda, kaliya tallaalka Pfizer ayaa lahaa oggolaanshahan.

Moderna, tallaalka mRNA waa tallaalka labaad ee ugu badan laga maamulo Faransiiska kadib Pfizer, oo leh 6.368.384 (isku darka irbado koowaad iyo labaad) dadka la tallaalay sida uu qabo CovidTracker. Sidaa darteed tani waa mid ka mid ah sababaha uu shaybaadhka Maraykanku isu dhigay bilowgii Juunyo si uu u codsado oggolaansho dhulkeenna. Sida lagu sheegay daraasad dhowaan ay samaysay shirkadda cilmiga bayoolajiga Maraykanka ee la daabacay May 25, serum ka hortagga Covid-19 ayaa la muujiyay. "Aad u hufan", taas oo ah, 93% dhalinyarada da'doodu u dhaxayso 12 ilaa 17. Waxaa loo yaqaan TeenCOVE, daraasadda shaybaadhka Moderna waxay ka qayb qaadatay in ka badan 3 ka qaybgalayaasha iyo "Walaac ku saabsan ammaankiisa lama sheegin ilaa hadda", wuxuu qeexayaa shaybaadhka.

"Guddiga Alaabada Dawooyinka ee Isticmaalka Aadanaha (...) ee AEM waxay ku talisay inay bixiso fidinta tilmaanta tallaalka Covid-19 Spikevax (oo hore u ahaan jirtay Covid-19 Vaccine Moderna) si loogu daro isticmaalka carruurta da'doodu u dhaxayso 12 ilaa 17 ", ayuu yiri maamulaha Yurub war-saxaafadeed.

Marka loo eego kororka kala duwanaanshaha Delta, masiibada Covid-19 diyaar uma aha inay quusto. Yurub dhexdeeda faafintiisu waa ku dhawaad ​​26%, tiradaas oo laga yaabo inay sare u kacdo mustaqbalka iyo in ka badan labanlaab afarta toddobaad ee soo socda. Mareykanka ayaa sidoo kale ku jira heerkan ugu sarreeya, oo uu ku faafay Covid-19 ku dhawaad ​​60%.